| The materials associated with these meetings are intended healthcare professionals and may refer to drug classes where Teva has a product and/or Teva products. This educational site for healthcare professionals has been initiated and funded by Teva. Prescribing Information is available here. |
| Adverse events should be reported: Reporting forms and information can be found at www.mhra.gov.uk/yellowcard (UK) or www.hpra.ie (ROI). Adverse events should also be reported to Teva using the Reporting Side Effects Form or telephone +44 (0)207 540 7117, or email uk.safety@tevauk.com. |
On Demand Recordings
Head Start Annual Meeting
This video collection is from Head Start's Annual Meeting, held in June 2024
Exploring the current headache landscape- what do the new guidelines mean for patient practice?
Discuss what the new guidelines mean for patient practice with Dr Jane Anderson
Exploring predictors of response to anti-CGRP monoclonal antibodies: latest clinical evidence
Explore the latest clinical data with Professor Cristina Tassorelli
Behavioural change for migraine prevention
Professor Ivo Vlaev discusses the application of behavioural science in migraine prevention
Unpacking the psychological impact of headaches and migraines
Dr Giorgio Lambru discusses psychological comorbidities
Cracking complex cases: complexities of comorbidities in headache
Complexities of comorbidities in headache with Dr David Moreno and Dr Maria Villar-Martinez
Care closer to home
Ms Anne-Marie Logan discusses headache service redesign to bring care into the community
Sleep Disorders
Dr Alexander Nesbitt provides an overview of sleep-related headache disorders
Headaches and Hormones
Understanding the relationships between female hormones and migraines with Dr Rebecca Walker
Next event
Head Start Events in 2025
We're finalising our event and webinar schedule for 2025
To ensure you receive information about future events, register your email with Teva.
This educational site for healthcare professionals has been initiated and funded by Teva.
Registered in England No. 302461. Registered office: Teva UK Limited, Ridings Point, Whistler Drive, Castleford, West Yorkshire, WF10 5HX
+44 (0) 1977 628500 | www.tevauk.com | Copyright © 2024 Teva UK Limited
Adverse events should be reported: Reporting forms and information can be found at www.mhra.gov.uk/yellowcard (UK) or www.hpra.ie (ROI). Adverse events should also be reported to Teva using the Reporting Side Effects Form or telephone +44 (0) 207 540 7117, or email uk.safety@tevauk.com.
Privacy Policy | Pharmacovigilance Privacy Policy | Terms and Conditions | Accessibility | Reporting Adverse Events